/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | WOKWORK Medical Technol |
|---|---|
| Last close | $1.00close 2026-11-02 |
| Change % | +0.00%close 2026-11-02 |
| Market cap | no share count |
| P/E | loss, no P/E |
| Revenue | $10M⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenueFromContractWithCustomerIncludingAssessedTax As ofFY ending 2025-09-30 Filing20-F · 0001213900-26-010301 · filed 2026-01-30 Open the filing on EDGAR →Open the XBRL payload →Cite |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | -14.4%FY to 2025-09-30 |
| Net income | $-1072667⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-09-30 Filing20-F · 0001213900-26-010301 · filed 2026-01-30 Open the filing on EDGAR →Open the XBRL payload →CiteWORK Medical Technology Group LTD (WOK), us-gaap:NetIncomeLoss: -1,072,667 USD, fiscal year ended 2025-09-30. Form 20-F, accession 0001213900-26-010301, filed 2026-01-30. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001929783/us-gaap/NetIncomeLoss.json |
| Net margin | -10.9%FY to 2025-09-30 |
| EPS (diluted) | $-0.04⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-09-30 Filing20-F · 0001213900-26-010301 · filed 2026-01-30 Open the filing on EDGAR →Open the XBRL payload →CiteWORK Medical Technology Group LTD (WOK), us-gaap:EarningsPerShareDiluted: -0.04 USD per share, fiscal year ended 2025-09-30. Form 20-F, accession 0001213900-26-010301, filed 2026-01-30. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001929783/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | not scored |
| Altman Z-ScoreUNVALIDATED | not scored |
| Beneish M-ScoreUNVALIDATED | not scored |
| Next earnings | — |